RAMP2, Human (Receptor Activity Modifying Protein2), Highly Purified

RAMP2, Human (Receptor Activity Modifying Protein2), Highly Purified
Item number Size Datasheet Manual SDS Delivery time Quantity Price
R1060-05A.100 100 µg - -

3 - 19 business days*

477.00€
 
Control Peptide for R1060-05B and R1060-05.||A 20aa Peptide mapping at the middle and a 9 aa... more
Product information "RAMP2, Human (Receptor Activity Modifying Protein2), Highly Purified"
Control Peptide for R1060-05B and R1060-05. A 20aa Peptide mapping at the middle and a 9 aa peptide mapping near the C-terminus of human RAMP2 . , The calcitonin family peptides probably act through G-protein coupled membrane receptors. The gene for calcitonin receptors has been cloned. It is homologous to GPCRs in family "B" which typically recognizes regulatory peptides (secretin, glucagons, VIP). Recently, a homolog of calcitonin receptor, CRLR (calcitonin-receptor-like receptor human 461 aa, rat/mouse 463 aa) was identified. CRLR has 55% homology with calcitonin receptor. It is now shown that CRLR can function as either a CGRP receptor or an ADM receptor, depending upon which members of a new family of proteins called receptor activity modifying proteins (RAMP1-3) are expressed. RAMPs1-3 contains an N-terminal signal peptide, an extracellular N-terminus, a single transmembrane domain near the C-terminus, and cytoplasmic C-terminus. RAMP1-3 displays 31% identity. RAMPS may be involved in the transport of CRLR to the plasma membrane. RAMP1 (human, mouse, rat 148 aa) presents the CRLR receptor as a glycoprotein that function as CGRP receptor. RAMP1 is expressed in many tissues, including the uterus, bladder, brain, pancreas, and GI tract. CRLR and RAMP1 are not co-expressed in all tissues suggesting that their co-expression may define which cells express functional CGRP receptors. RAMP2 (human 175 aa, rat 182 aa, and mouse 189 aa)-transported receptors are core-glycosylated and function as ADM receptor. It is expressed in the lung, breast, immune system and fetal tissues. RAMP3 is most abundant in the kidney and lung. Applications: Suitable for use in ELISA and Antibody Blocking. Not suitable for use in Western Blot. Other applications not tested. Recommended Dilution: EAntibody Blocking: 5-10ug per 1ul R1060-05B or per 1ug R1060-05 , ELISA: 1ug/ml. , Optimal dilutions to be determined by the researcher. , Optimal dilutions to be determined by the researcher. Species sequence homology: , Storage and Stability:, May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Keywords: RAMP2, CRLR activity-modifying protein 2, Receptor activity-modifying protein 2, Calcitonin-receptor-like receptor activity-modifying protein 2
Supplier: United States Biological
Supplier-Nr: R1060-05A

Properties

Application: Control peptide
Conjugate: No
Species reactivity: mouse, rat
Format: Highly Purified

Database Information

KEGG ID : K08448 | Matching products
UniProt ID : O60895 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "RAMP2, Human (Receptor Activity Modifying Protein2), Highly Purified"
Write a review
or to review a product.
Viewed